PDA invite you to complete our Pharmacists Working in General Practice Survey

It’s almost two years since the PDA did its UK-wide survey of pharmacists working in general practice. Since then there have been many and various developments across the four nations of the UK - including the commitment in Scotland to pharmaceutical care through the Achieving Excellence Strategy, and most recently the announcement of the new GP contract for England.

Fri 17th May 2019 The PDA

It is clear that there is a positive commitment to provide ongoing and sustained investment for more pharmacists to work in general practice.

We are keen to understand how the primary care landscape has changed since the last survey, and how recent developments are affecting GP pharmacists. We hope to use the results of this survey to guide how we are best able to support the needs of individual pharmacists and continue to proactively lobby their agenda.

We are asking all pharmacists who work in a GP practice, part-time or full-time, and regardless of employment status, to complete this survey. You do not need to be a PDA member.

This survey should take approximately 5 minutes to complete.


View the results of our last general practice survey here.


The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)